T. Rowe Price Associates »

Tango Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $113k 11k 9.96
2023-09-30 $116k 10k 11.35

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Tango Therapeutics

Trv Gp Iv
EcoR1 Capital
Boxer Capital
Nextech Invest
Southpoint Capital Advisors
Vanguard Group
Deerfield Management Company
Casdin Capital
Perceptive Advisors
Soleus Capital Management
Baker Bros. Advisors
Arrowpoint Asset Management
Bessemer
Samsara BioCapital
Goldman Sachs Group

View all funds holding Tango Therapeutics